NAVAMEDIC ASA NK 1
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutritio… Read more
NAVAMEDIC ASA NK 1 (N1A) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, NAVAMEDIC ASA NK 1 (N1A) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NAVAMEDIC ASA NK 1 - Net Assets Trend (None–None)
This chart illustrates how NAVAMEDIC ASA NK 1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NAVAMEDIC ASA NK 1 (None–None)
The table below shows the annual net assets of NAVAMEDIC ASA NK 1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to NAVAMEDIC ASA NK 1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
NAVAMEDIC ASA NK 1 Competitors by Market Cap
The table below lists competitors of NAVAMEDIC ASA NK 1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Arctic Fish Holding AS
OL:AFISH
|
$29.36 Million |
|
INDICE FINANCEIRO
SA:IFNC
|
$29.37 Million |
|
PT Pakuwon Jati Tbk
OTCGREY:PTPKF
|
$29.38 Million |
|
Country Group Holdings Public Company Limited
BK:CGH
|
$29.38 Million |
|
MMC Sanayi ve Ticari Yatirimlar AS
IS:MMCAS
|
$29.35 Million |
|
Krungdhep Sophon Public Company Limited
BK:KWC
|
$29.35 Million |
|
Astra Graphia Tbk
JK:ASGR
|
$29.34 Million |
|
Diamond Food Indonesia PT
JK:DMND
|
$29.33 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NAVAMEDIC ASA NK 1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares NAVAMEDIC ASA NK 1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently NAVAMEDIC ASA NK 1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares NAVAMEDIC ASA NK 1's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,192,244,105,699
- Average return on equity (ROE) among peers: -83.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NAVAMEDIC ASA NK 1 (N1A) | €- | N/A | N/A | $29.35 Million |
| KIMIA FARMA -B- (HQP) | $5.89 Trillion | 5.13% | 1.93x | $78.59 Million |
| Asker Healthcare Group AB (I88) | $3.50 Billion | 10.28% | 2.75x | $1.37 Billion |
| Paragon Care Limited (PXS) | $18.21 Million | 5.96% | 0.48x | $52.86 Million |
| TELES Informationstechnologien AG (TLIK) | $379.23K | -446.97% | 3.69x | $801.14K |
| Sinopharm Group Co. Ltd (X2S) | $68.28 Billion | 8.55% | 2.45x | $3.27 Billion |